Antiviral agents for hepatitis B

Abstract

HepatologyVolume 14, Issue 1 p. 198-199 EditorialFree Access Antiviral agents for hepatitis B John L. Gerin Ph.D., Corresponding Author John L. Gerin Ph.D. Division of Molecular Virology and Immunology Georgetown University Medical Center Rockville, Maryland 20852Georgetown University, 5640 Fishers Lane, Rockville, MD 20852===Search for more papers by this author John L. Gerin Ph.D., Corresponding Author John L. Gerin Ph.D. Division of Molecular Virology and Immunology Georgetown University Medical Center Rockville, Maryland 20852Georgetown University, 5640 Fishers Lane, Rockville, MD 20852===Search for more papers by this author First published: July 1991 https://doi.org/10.1002/hep.1840140132Citations: 9AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Ponzetto A, Forzani B, Busi C, Spinelli S, Smedile A, Bonino F, Verme G. Adenine arabinoside monophosphate and acyclovir monophosphate coupled to lactosaminated albumin inhibit woodchuck hepatitis virus replication at low doses. HEPATOLOGY 1991; 14: 16– 23. 2 Pollard RB, Smith JL, Beal A, Gregory PB, Merigan TC, Robinson WS. Effect of vidarabine on chronic hepatitis B infection. JAMA 1978; 239: 1648. 3 Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, et al. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology 1984; 86: 150– 157. 4 Weller IVD, Lok ASF, Mindel A, Karayiannis P, Galpin S, Monjardino J, Sherlock S, et al. Randomized controlled trial of adenine arabinoside 5′-monophosphate (ara-AMP) in chronic hepatitis B virus infection. Gut 1985; 26: 745– 751. 5 Lok ASF, Wilson LA, Thomas HC. Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection. J Antimicrob Chemother 1984; 14: 93– 99. 6 Perrillo RP. Treatment of chronic hepatitis B with interferon: experience in Western countries. Semin Liver Dis 1989; 9: 240– 248. 7 Scullard GH, Andress LL, Greenberg HB, Smith JL, Sawhney VK, Neal EA, Mahal AS, et al. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside. HEPATOLOGY 1981; 1: 228– 232. 8 Robinson WS. Hepadnaviridae and their replication. In: Hollinger FB, Robinson WS, Purcell RH. Viral Hepatitis, 2nd Edition, Raven Press, New York, 1991; p. 39– 71. 9 Fiume L, Busi C, Mattioli A, Spinosa G. Targeting of antiviral drugs bound to protein carriers. Crit Ther Drug Carrier Sys 1988; 4: 265– 284. 10 Fiume L, Torrani-Cerenzia MR, Bonino F, Busi C, Mattioli A, Brunetto MR, Chiaberge E, et al. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin. Lancet 1988; 2: 13– 15. 11 Hirota K, Sherker AH, Omata M, Yokosuka O, Okuda K. Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection. HEPATOLOGY 1987; 7: 24– 28. 12 Petcu DJ, Aldrich CE, Coates L, Taylor JM, Mason WS. Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus. Virology 1988; 167: 385– 392. 13 Gerin JL, Cote PJ, Korba BE, Tennant BC. Hepadnavirus-induced liver cancer in woodchucks. Cancer Detect Prev 1989; 14: 227– 229. 14 Tennant BC, Hornbuckle WE, Baldwin BH, King JM, Cote P, Popper H, Purcell RH, et al. Influence of age on the response to experimental woodchuck hepatitis virus infection. In: AJ Zuckerman, ed. Viral hepatitis and liver disease New York: Alan R. Liss, Inc., 1988: 462– 464. 15 Korba BE, Cote PJ, Wells FV, Baldwin B, Cote PJ, Tennant BC, Popper H, et al. Natural history of WHV infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues. J Virol 1989; 63: 1360– 1370. Citing Literature Volume14, Issue1July 1991Pages 198-199 ReferencesRelatedInformation